Company Laboratorio Reig Jofre, S.A.

Equities

RJF

ES0165359029

Pharmaceuticals

Market Closed - BME 11:35:10 2024-04-30 am EDT 5-day change 1st Jan Change
2.49 EUR -0.80% Intraday chart for Laboratorio Reig Jofre, S.A. -1.19% +10.67%

Business Summary

Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.

Number of employees: 1,331

Sales per Business

EUR in Million2022Weight2023Weight Delta
Pharmaceutical Services
81.0 %
217 80.0 % 256 81.0 % +18.06%
Nutritional Supplements
19.0 %
54 20.0 % 60 19.0 % +10.62%

Sales per region

EUR in Million2022Weight2023Weight Delta
Spain
44.6 %
119 43.7 % 141 44.6 % +18.98%
European Union
36.5 %
110 40.7 % 115 36.5 % +4.56%
Asia
8.1 %
16 5.8 % 26 8.1 % +62.90%
Rest of Europe
7.0 %
17 6.2 % 22 7.0 % +33.15%
Africa
1.6 %
4 1.6 % 5 1.6 % +18.44%
Americas
1.3 %
3 1.2 % 4 1.3 % +26.07%
Oceania
0.7 %
2 0.7 % 2 0.7 % +15.34%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 05-12-31
Chief Tech/Sci/R&D Officer - 02-12-31
Chief Operating Officer 52 02-12-31
- -
Investor Relations Contact - 09-12-31
Corporate Officer/Principal - -
Comptroller/Controller/Auditor - 00-12-31
Corporate Secretary 56 14-12-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 56 05-12-31
Director/Board Member - 14-12-30
Director/Board Member - 14-12-30
Director/Board Member 70 20-07-22
Director/Board Member - 14-12-30
Chairman - 14-12-30
Director/Board Member - 17-11-06
Director/Board Member - 14-12-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 79,635,945 15,918,841 ( 19.99 %) 836,927 ( 1.051 %) 19.99 %

Shareholders

NameEquities%Valuation
Reig Jofre Investments SL
61.79 %
49,210,192 61.79 % 132 M €
7,881,473 9.897 % 21 M €
4,807,306 6.037 % 13 M €
Quaero Capital SA
3.005 %
2,393,424 3.005 % 6 M €
832,832 1.046 % 2 M €
Caixabank Asset Management SGIIC SA
0.5286 %
420,919 0.5286 % 1 M €
Solventis SGIIC SA
0.4394 %
349,930 0.4394 % 941 032 €
Andbank Wealth Management SGIIC SAU
0.2828 %
225,195 0.2828 % 605 594 €
Quadriga Asset Managers SGIIC SA
0.1946 %
155,000 0.1946 % 416 826 €
GVC Gaesco Gestión SGIIC SA
0.1388 %
110,506 0.1388 % 297 173 €

Holdings

NameEquities%Valuation
832,832 1.05% 2,239,652 $

Company contact information

Laboratorio Reig Jofre SA

Gran Capita, 10 Sant Joan Despi

08970, Barcelona

+34 93 480 67 10

http://www.reigjofre.com
address Laboratorio Reig Jofre, S.A.(RJF)
  1. Stock Market
  2. Equities
  3. RJF Stock
  4. Company Laboratorio Reig Jofre, S.A.